Potential of essential fatty acids as natural therapeutic products for human tumors

Nutrition

Volumn 19, Issue 4, 2003, Pages 386-388

  Eynard, Aldo R ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ARACHIDONIC ACID; CATALASE; CYTOKINE; DNA; DOCOSAHEXAENOIC ACID; ESSENTIAL FATTY ACID; GAMMA LINOLENIC ACID; GLUCOCORTICOID; ICOSANOID; LINOLEIC ACID; LINOLEOYL COENZYME A DESATURASE; LIPID PEROXIDE; LONG CHAIN FATTY ACID; OLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; THROMBOXANE SYNTHASE; TUBULIN;

ASTROCYTE; BRAIN TUMOR; BREAST CANCER; CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RISK; CELL DIFFERENTIATION; CELL PROLIFERATION; COLON CANCER; DNA SYNTHESIS INHIBITION; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; FAT INTAKE; FATTY ACID DESATURATION; GLIOMA; HUMAN; LIPID COMPOSITION; LIPID METABOLISM; LIPID PEROXIDATION; LIPOGENESIS; MALIGNANT TRANSFORMATION; MAMMAL CELL; MICROTUBULE ASSEMBLY; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; SEA FOOD; SHORT SURVEY; TUMOR; TUMOR CELL; TUMOR PROMOTION;

MAMMALIA;

EID: 0037382535     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(02)00956-5     Document Type: Editorial

References (39)

1. Holman R.T. How essential are fatty acids? JAMA. 178:1961;930.
2. Holman R.T., Mohrhauer H. A hypothesis involving competitive inhibition in the metabolism of polyunsaturated fatty acids. Acta Chem Scand. 17:1963;584.
3. Brenner R.R. Nutritional and hormonal factors influencing desaturation of essential fatty acids. Prog Lipid Res. 20:1981;41.
4. Dunbar L.M., Bailey J.M. Enzyme deletions and essential fatty acid metabolism in cultured cells. J Biol Chem. 250:1975;1152.
5. De Antueno R.J., Niedefeld G., De Tomas M.E., et al. Microsomal fatty acid desaturation and elongation in a human lung carcinoma grown in nude mice. Biochem Int. 16:1988;413.
6. Grammatikos S.I., Harvey M.J., Subbaiah P.V., et al. Loss of fatty acid delta-6 desaturating ability in human mammary epithelial cells that express an activated c-Ha-ras oncogene. Int J Oncol. 6:1995;1039.
7. Guarnieri M., Jhonson R.M. The essential fatty acids. Adv Lipid Res. 8:1970;115.
8. Struijk CB, Beerthuis RK, Pabon HJJ, et al. Specificity in the enzymic conversion of polyunsaturated fatty acids into prostaglandins. Recueil Travaux Quimiq Pays Bas 1966;T85:1233.
9. Fermor B.F., Masters J.R.W., Wood C.B., et al. Fatty acid composition of normal and malignant cells and cytotoxicity of stearic, oleic and sterculic acids in vitro. Eur J Cancer. 28:1992;1143.
10. Bardon S., Le M.T., Alessandri J.M. Metabolic conversion and growth effects of n-6 and n-3 polyunsaturated fatty acids in the T47D breast cancer cell line. Cancer Lett. 99:1996;51.
11. Greenwald P., Clifford C.K., Milner J.A. Diet and cancer prevention. Eur J Cancer. 37:2001;948.
12. Willett W.C. Diet and cancer one view at the start of the millennium . Cancer Epidemiol Biomarkers Prev. 10:2001;3.
13. Willett W.C., Stampfer M.J., Colditz G.A., et al. Relation of meat, fat and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med. 323:1990;1664.
14. Navarro A., Osella A.R., Muñoz S.E., et al. Fatty acids, fibres and colorectal cancer risk in Córdoba, Argentina. J Epidemiol Biostat. 3:1998;415.
15. Bakshi A, Mukherjee D, Banerji AK, et al. Gamma-linolenic acid therapy of human gliomas. Nutrition 2002;19:305.
16. Nyrop J.E. Hardened fats and lung cancer. Lancet. 2:1954;1288.
17. Sinclair H.M. Deficiency of essential fatty acids and atherosclerosis, etc. Lancet. 1:1956;381.
18. Sinclair H.M. Essential fatty acids and their relation to pyridoxine. Biochem Soc Symp. 9:1952;80.
19. McClinton S., Moffat L.E.F., Horrobin D.F., et al. Abnormalities of essential fatty acid distribution in the plasma phospholipids of patients with bladder cancer. Br J Cancer. 63:1991;314.
20. Eynard A.R. Does chronic essential fatty acid deficiency (EFAD) constitute a protumorigenic condition? Med Hypotheses. 48:1997;55.
21. Eynard A.R. Is the risk of urinary tract tumorigenesis enhanced by a marginal chronic essential fatty acid deficiency (EFAD) ? Nutrition. 14:1998;211.
22. Das U.N. Cis-unsaturated fatty acids as potential anti-mutagenic, tumoricidal and anti-metastatic agents. Asia Pac J Pharmacol. 7:1992;305.
23. Das U.N. Essential fatty acids and their metabolites and cancer. Nutrition. 15:1999;239.
24. Das U.N. Anti-cancer actions of gamma-linolenic acid with particular reference to human brain malignant glioma. Huang Y.S., Mills D.E. Gamma-linolenic acid: metabolism and role in nutrition and medicine. 1996;282 AOCS Press, Illinois.
25. Cantrill R.C., Huang Y.S. Fatty acid and cancer. Nutrition. 14:1998;235.
26. Jiang W.G., Redfern A., Eynard A., et al. Polyunsaturated fatty acids and their role in cancer invasion and metastasis. Jiang W.G., Mansel R.E. Cancer metastasis, molecular and cellular mechanisms and clinical intervention. 2000;225 Kluwer Academic Publishers, Amsterdam.
27. Cremonezzi D.C., Silva R.A., Díaz M.P., et al. Dietary polyunsaturated fatty acids (PUFA) differentially modulate melamine-induced pre- and neoplastic urothelial proliferation and apoptosis in mice. Prostaglandin Leukot Essent Fatty Acids. 64:2001;151.
28. Burdge G.C., Rodway H., Kohler J.A., et al. Effect of fatty acid supplementation on growth and differentiation of human IMR-32 neuroblastoma cells in vitro. J Cell Biochem. 80:2000;266.
29. Calderon R.O., Glocker M.T., Eynard A.R. Lipids and fatty acid composition of different fractions from rat urinary transitional epithelium. Lipids. 33:1998;1017.
30. Calderon R.O., Eynard A.R. "Fatty acids specifically related to the anisotropics properties of plasma membrane from rat urothelium. " Biochim Biophys Acta. 1483:2000;174.
31. Horrobin D.F. Essential fatty acids, lipid peroxidation and cancer. Horrobin D.F. Omega 6 essential fatty acids: pathophysiology and roles in clinical medicine. 1990;351 Alan Liss, New York.
32. Takeda S., Sim P.G., Horrobin D.F., et al. Mechanism of lipid peroxidation in cancer cells in response to gamma-linolenic acid (GLA) analyzed by GC-MS (I) conjugated dienes with peroxyl (or hydroperxyl) groups and cell-killing effects . Anticancer Res. 13:1993;193.
33. Vartak S., McCaw R., Davis C.S., et al. Gamma-linolenic acid (GLA) is cytotoxic to 36B10 malignant rat astrocytoma cells but not to 'normal' rat astrocytes. Br J Cancer. 77:1998;1612.
34. Preuss M., Girnun G.D., Darby C.J., et al. Role of antioxidant enzyme expression in the selective cytotoxic response of glioma cells to gamma-linolenic acid supplementation. Free Radic Biol Med. 28:2000;1143.
35. Neely M.D., Sidell K.R., Graham D.G., et al. The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin. J Neurochem. 72:1999;2323.
36. Matsuo M., Yonemitsu N., Zaitsu M., et al. Expression of prostaglandin H synthase-2 in human brain tumors. Acta Neuropathol. 102:2001;181.
37. Giese A., Hagel C., Kim E.L., et al. Thromboxane synthase regulates the migratory phenotype of human glioma cells. Neurooncology. 1:1999;3.
38. Fiebich B.L., Schleicher S., Spleiss O., et al. Mechanisms of prostaglandin E2-induced interleukin-6 release in astrocytes possible involvement of EP4-like receptors, p38 mitogen-activated protein kinase and protein kinase C . J Neurochem. 79:2001;950.
39. Hoozemans J.J., Veerhuis R., Janssen I., et al. Interleukin-1beta induced cyclooxygenase 2 expression and prostaglandin E2 secretion by human neuroblastoma cells implications for Alzheimer's disease . Exp Gerontol. 36:2001;559.